​

Tvardi Therapeutics Ownership | Who Owns Tvardi Therapeutics?


OverviewForecastChart

Tvardi Therapeutics Ownership Summary


Tvardi Therapeutics is owned by 23.81% institutional investors, 24.36% insiders, and 51.83% retail investors. Slate path capital lp is the largest institutional shareholder, holding 9.49% of TVRD shares. Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund, with 2.75% of its assets in Tvardi Therapeutics shares.

TVRD Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTvardi Therapeutics23.81%24.36%51.83%
SectorHealthcare Stocks 247.07%12.15%-159.22%
IndustryBiotech Stocks 385.89%11.79%-297.68%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Slate path capital lp704.12K9.49%$2.24M
Vanguard group424.82K4.53%$1.83M
Vanguard capital management344.38K3.68%$430.48K
Raymond james financial278.57K2.98%$348.21K
American financial group223.66K2.39%$279.57K
Jpmorgan chase202.47K2.16%$259.17K
Captrust financial advisors200.50K2.14%$250.63K
683 capital management176.03K2.13%$6.77M
Vestal point capital, lp167.00K2.03%$6.51M
Renaissance134.14K1.43%$167.68K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
683 capital management176.03K0.35%$6.77M
Vestal point capital, lp167.00K0.29%$6.51M
Parkman healthcare partners65.00K0.26%$2.53M
American financial group223.66K0.10%$279.57K
Slate path capital lp704.12K0.03%$2.24M
Diadema partners lp2.19K0.02%$85.15K
Duncan williams asset management63.24K0.02%$79.05K
Boothbay fund management20.19K0.01%$786.76K
Persistent asset partners12.33K0.00%$15.41K
Schonfeld strategic advisors19.13K0.00%$745.57K

Top Buyers

HolderShares% AssetsChange
Raymond james financial278.57K0.00%278.57K
Jpmorgan chase202.47K-202.35K
Captrust financial advisors200.50K0.00%200.50K
Vestal point capital, lp167.00K0.29%167.00K
Verition fund management87.00K0.00%87.00K

Top Sellers

HolderShares% AssetsChange
Ubs group48.00--111.08K
Jane street group---47.44K
Great lakes advisors---36.24K
Russell investments group7.98K--35.25K
Squarepoint ops---32.68K

New Positions

HolderShares% AssetsChangeValue
Raymond james financial278.57K0.00%278.57K$348.21K
Captrust financial advisors200.50K0.00%200.50K$250.63K
Vestal point capital, lp167.00K0.29%167.00K$6.51M
Verition fund management87.00K0.00%87.00K$108.75K
Invesco82.61K0.00%82.61K$3.22M

Sold Out

HolderChange
Cornerstone planning group-1.00
Sjs investment consulting-1.00
Axiom investment management-1.00
Sound income strategies-2.00
True wealth design-2.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202659-10.61%2,227,893-17.58%232.87%21-40.00%2450.00%
Mar 31, 202632-50.77%634,949-77.52%80.94%21-52.27%4-33.33%
Dec 31, 202548-28.36%1,830,953-29.68%191.96%33-26.67%4-33.33%
Sep 30, 202537-22.92%1,220,244-36.55%143.50%27-43.75%3-
Jun 30, 202530-897,987-9-30---

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Morn Total Stk Mkt Idx Investor258.43K2.75%-
Vanguard Total Stock Mkt Idx Inv258.43K2.75%-
Vanguard MStar Total Stk Mkt Idx Invest258.43K1.94%-
iShares Russell 2000 ETF157.86K1.68%1.46K
Vanguard Institutional Extnd Mkt Idx Tr85.96K0.92%-
Fidelity Small Cap Index59.91K0.64%860.00
Fidelity Extended Market Index71.76K0.54%-271.00
iShares Russell 2000 Value ETF35.46K0.38%-
Russell 2000 Equity Index Fund B31.18K0.33%70.00
Russell 2000 Index Non-Lendable Fund31.18K0.33%31.18K

Insider Transactions Trends


DateBuySell
2026 Q2--
2026 Q1--
2025 Q4--
2025 Q3--
2025 Q2--

TVRD Ownership FAQ


Who Owns Tvardi Therapeutics?

Tvardi Therapeutics shareholders are primarily institutional investors at 23.81%, followed by 24.36% insiders and 51.83% retail investors. The average institutional ownership in Tvardi Therapeutics's industry, Biotech Stocks , is 385.89%, which Tvardi Therapeutics falls below.

Who owns the most shares of Tvardi Therapeutics?

Tvardi Therapeutics’s largest shareholders are Slate path capital lp (704.12K shares, 9.49%), Vanguard group (424.82K shares, 4.53%), and Vanguard capital management (344.38K shares, 3.68%). Together, they hold 17.70% of Tvardi Therapeutics’s total shares outstanding.

Does Blackrock own Tvardi Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Tvardi Therapeutics.

Who is Tvardi Therapeutics’s biggest shareholder by percentage of total assets invested?

683 capital management is Tvardi Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.35% of its assets in 176.03K Tvardi Therapeutics shares, valued at 6.77M$.

Who is the top mutual fund holder of Tvardi Therapeutics shares?

Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund holder of Tvardi Therapeutics shares, with 2.75% of its total shares outstanding invested in 258.43K Tvardi Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools